Key facts
- Germitec’s last known valuation is $137.0M (Feb 2025).
- It has raised $77.0M; the latest was Later Stage VC ($30.0M) in Feb 2025.
- Notable investors include Kurma Partners, Turenne Groupe, AQUITI Gestion, Eurazeo, Financiere Arbevel — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Germitec
- ·The full record, as it builds
Funding rounds
No funding rounds for Germitec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Germitec
Manufacturer of disinfection systems intended to develop hospital hygiene systems that radically simplify the lives of healthcare professionals in terms of safety, time and responsibility. The company specializes in ultraviolet light high-level disinfection (UV-C HLD) for reprocessing non-lumen medical devices, enabling medical staff to change clinical practice in reducing cross-infection risk.
- Sector
- Healthcare
- HQ
- Bordeaux, France
- Founded
- 2005
- Employees
- 45
- Website
- germitec.com/
- Ownership
- Privately Held (backing)
Germitec doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Germitec shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Germitec in its N-PORT filings yet. We sweep new filings monthly.